Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine

John Litt, Susan Kim, Richard Woodman, Raina MacIntyre, Tony Cunningham

    Research output: Contribution to journalMeeting Abstract

    Abstract

    Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.
    Original languageEnglish
    Pages (from-to)436-437
    Number of pages2
    JournalInternational Journal of Infectious Diseases
    Volume21
    Issue numberSupplement 1
    DOIs
    Publication statusPublished - Apr 2014
    Event16th International Congress on Infectious Diseases - Cape Town, South Africa
    Duration: 2 Apr 20145 Apr 2014
    Conference number: 16

    Bibliographical note

    This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.

    Keywords

    • shingles
    • vaccination
    • vaccine
    • older adults
    • older persons

    Fingerprint Dive into the research topics of 'Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine'. Together they form a unique fingerprint.

  • Cite this